Healthy Subject
Conditions
Keywords
Cancer prevention, HPV, Human papillomavirus vaccine
Brief summary
This randomized pilot trial studies how well a mobile health (mHealth) intervention works in increasing human papillomavirus (HPV) vaccination among college students at the Ohio State University. mHealth educational intervention may communicate information about HPV vaccination and increase HPV vaccine uptake in college students.
Detailed description
PRIMARY OBJECTIVES: I. Pilot test an mHealth HPV vaccine intervention for college students to establish feasibility and acceptability. II. Obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group. SECONDARY OBJECTIVES: I. Examine whether the mHealth HPV vaccine intervention affects secondary outcomes compared to the control group. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message. ARM II: Participants receive standard information about HPV and then HPV vaccine information statement (VIS) via the mobile-friendly website. After completion of study, participants are followed up at 3 and 7 months.
Interventions
OTHERInformational Intervention
Receive standard HPV vaccine information (HPV VIS)
OTHERMedia Intervention
Receive targeted HPV vaccine narrative-style video
OTHERSurvey Administration
Ancillary studies
Sponsors
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
Yes
Inclusion criteria
* Currently enrolled as a first year Ohio State University (OSU) student on the Columbus campus * Being able to read English * Not having received any doses of the HPV vaccine
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Receipt of the first dose of HPV vaccine in intervention and control group | Up to 7 months | Will obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group. |
| Participant satisfaction scores | Up to 7 months | Acceptability and feasibility will be established by examining participant satisfaction with study materials. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Student feedback based on satisfaction and usability data assessed by surveys | Up to 7 months | — |
| Number of times participant logged in to view the narrative or HPV VIS | Up to 7 months | — |
| Receipt of the second and third doses of the HPV vaccine series by intervention and control group | Up to 7 months | Will examine whether the mHealth HPV vaccine intervention affects the receipt of the second and third doses of the HPV vaccine series compared to the control group. |
| Total time spent viewing the narrative-style video or HPV VIS | Up to 7 months | — |
| Number of times participants in the intervention group used the link to make an appointment at the health center | Up to 7 months | — |
| Changes in potential mediators between intervention or control group and HPV vaccination | Up to 7 months | Will examine whether the mHealth HPV vaccine intervention affects changes in potential mediators between intervention group and HPV vaccination compared to the control group. |
Countries
United States
Outcome results
None listed